Notice Pursuant to the National Cooperative Research and Production Act of 1993-Medical Technology Enterprise Consortium, 18864 [2019-08997]

Download as PDF 18864 Federal Register / Vol. 84, No. 85 / Thursday, May 2, 2019 / Notices National Cooperative Research and Production Act of 1993, 15 U.S.C. 4301 et seq. (‘‘the Act’’), National Shipbuilding Research Program (‘‘NSRP’’) has filed written notifications simultaneously with the Attorney General and the Federal Trade Commission disclosing changes in its membership. The notifications were filed for the purpose of extending the Act’s provisions limiting the recovery of antitrust plaintiffs to actual damages under specified circumstances. Specifically, Vigor Marine LLC, Seattle, WA, has been added as a party to this venture. No other changes have been made in either the membership or planned activity of the group research project. Membership in this group research project remains open, and NSRP intends to file additional written notifications disclosing all changes in membership. On March 13, 1998, NSRP filed its original notification pursuant to Section 6(a) of the Act. The Department of Justice published a notice in the Federal Register pursuant to Section 6(b) of the Act on January 29, 1999 (64 FR 4708). The last notification was filed with the Department on January 16, 2019. A notice was published in the Federal Register pursuant to Section 6(b) of the Act on February 12, 2019 (84 FR 3492). Suzanne Morris, Chief, Premerger and Division Statistics Unit, Antitrust Division. [FR Doc. 2019–08995 Filed 5–1–19; 8:45 am] BILLING CODE 4410–11–P DEPARTMENT OF JUSTICE Antitrust Division khammond on DSKBBV9HB2PROD with NOTICES Notice Pursuant to the National Cooperative Research and Production Act of 1993—Medical Technology Enterprise Consortium Notice is hereby given that, on April 8, 2019, pursuant to Section 6(a) of the National Cooperative Research and Production Act of 1993, 15 U.S.C. 4301 et seq. (‘‘the Act’’), Medical Technology Enterprise Consortium (‘‘MTEC’’) has filed written notifications simultaneously with the Attorney General and the Federal Trade Commission disclosing changes in its membership. The notifications were filed for the purpose of extending the Act’s provisions limiting the recovery of antitrust plaintiffs to actual damages under specified circumstances. Specifically, Securisyn Medical, LLC, Highlands Ranch, CO; Polaris Alpha Advanced Systems, Inc., Aberdeen Proving Ground, MD; Arrevus, Inc., VerDate Sep<11>2014 18:51 May 01, 2019 Jkt 247001 Raleigh, NC; Initiate Government Solutions, LLC, North Palm Beach, FL; 7–SIGMA Incorporated, Minneapolis, MN; MAE Group, Deerfield, NH; Radical Concepts LLC, Brooklyn, NY; Next Generation Stretcher Ltd, Raman gan, Israel; Pop Test Oncology LLC aka Palisades Therapeutics, Cliffside Park, NJ; George Mason University, Manassas, VA; Phagelux (Canada) Inc., Montre´al, CANADA; MY01 Inc., Montreal, CANADA; MilanaPharm, LLC, Tallassee, AL; Leidos, Inc., Reston, VA; InfraScan, Inc., Philadelphia, PA; NuShores Biosciences LLC, Little Rock, AR; Seran Bioscience, Bend, OR; Celularity, Warren, NJ; Droper Med America, LLC, Elgin, SC; tesa Labtec GmbH, Langenfeld, GERMANY; Bio Med Sciences, Inc., Allentown, PA; Uluru Inc., Addison, TX; Trailhead Biosystems Inc., Cleveland, OH; 410 Medical, Inc., Durham, NC; Knowledge Driven LLC, Alexandria, VA; Arsenal Medical, Inc., Watertown, MA; University of North Carolina, Institute for Trauma Recovery, Chapel Hill, NC; Prep Tech, LLC, Westlake, LA; 21 MedTech, LLC, Burlington, NC; Integrum Scientific, LLC, Greensboro, NC; HYPR Life Sciences, Inc., Pilot Mountain, NC; X-Therma Inc., Richmond, CA; VoluMetrix LLC, Nashville, TN; Howmedica Osteonics Corp. dba Stryker Orthopaedics, Mahwah, NJ; NeuEsse Inc., Dunbar, PA; The Geneva Foundation, Tacoma, WA; Scinus Cell Expansion B.V., Bilthoven, THE NETHERLANDS; Akron Biotechnology, LLC, Boca Raton, FL; RoosterBio Inc., Frederick, MD; Aptitude Medical Systems, Santa Barbara, CA; Rho Federal Systems Division, Inc. (RhoFED), Chapel Hill, NC; HeadsafelP Pty Ltd Bronte, AUSTRALIA; Truecath Inc., Camarillo, CA; Solutions Through Innovative Technologies, Inc., Fairborn, OH; Sempulse, LLC, San Marcos, TX; The Curators of the University of Missouri on behalf of the University of MissouriKansas City, Kansas City, MO; Cognitive Medical Systems, Inc., San Diego, CA; Hemoclear B.V., Zwolle, NETHERLANDS; Immunexpress Inc., Seattle, WA; Klox Technologies, Inc., Laval, CANADA; Opticyte, Inc., Seattle, WA; Physcient, Inc., Durham, NC; ActiBioMotion, LLC, Coralville, IA; Detact Diagnostics BV, Gronigen, THE NETHERLANDS; SurgiBox Inc., Brookline, MA; Cincinnati Automation & Mechatronics, LLC, Beavercreek, OH; and Molecular Biologicals, Pasadena, TX; have been added as parties to this venture. Also, Tallinn University of Technology, Tallin, Estonia; National PO 00000 Frm 00102 Fmt 4703 Sfmt 4703 Trauma Institute dba Coalition for National Trauma Research, Marietta, TX; East Carolina University, Greenville, NC; EyeSonix LLC, Long Beach, CA; ElMindA Ltd., Herzliya, ISRAEL; Propagenix Inc., Rockville, MD; Studio Kinection, Inc. dba Kinection, Napa, CA; The Ohio State University, Columbus, OH; Elemance, LLC, Clemmons, NC; J. Craig Venter Institute (JCVI), Rockville, MD; LambdaVision Incorporated, Farmington, CT; Michigan State University, East Lansing, MI; Corvid Technologies, Mooresville, NC; Spire, San Francisco, CA; United Solutions, LLC, Rockville, MD; Aleo BME, Inc., State College, PA; Cell Guidance Systems Ltd, Cambridge, UK; Cole Engineering Services, Inc., Orlando, FL; FlexDex, Inc., Brighton, MI; Fortuna Fix, London, UK; Hypatia Project, Reston, VA; and MiMedx Group Inc., Marietta, GA; have withdrawn as parties to this venture. No other changes have been made in either the membership or planned activity of the group research project. Membership in this group research project remains open, and MTEC intends to file additional written notifications disclosing all changes in membership. On May 9, 2014 MTEC filed its original notification pursuant to Section 6(a) of the Act. The Department of Justice published a notice in the Federal Register pursuant to Section 6(b) of the Act on June 9, 2014 (79 FR 32999). The last notification was filed with the Department on January 28, 2019. A notice was published in the Federal Register pursuant to Section 6(b) of the Act on February 28, 2019 (84 FR 6824). Suzanne Morris, Chief, Premerger and Division Statistics Unit, Antitrust Division. [FR Doc. 2019–08997 Filed 5–1–19; 8:45 am] BILLING CODE 4410–11–P DEPARTMENT OF JUSTICE Antitrust Division Notice Pursuant to the National Cooperative Research and Production Act of 1993—Pistoia Alliance, Inc. Notice is hereby given that, on April 8, 2019, pursuant to Section 6(a) of the National Cooperative Research and Production Act of 1993, 15 U.S.C. 4301 et seq. (‘‘the Act’’), Pistoia Alliance, Inc. has filed written notifications simultaneously with the Attorney General and the Federal Trade Commission disclosing changes in its membership. The notifications were E:\FR\FM\02MYN1.SGM 02MYN1

Agencies

[Federal Register Volume 84, Number 85 (Thursday, May 2, 2019)]
[Notices]
[Page 18864]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-08997]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Antitrust Division


Notice Pursuant to the National Cooperative Research and 
Production Act of 1993--Medical Technology Enterprise Consortium

    Notice is hereby given that, on April 8, 2019, pursuant to Section 
6(a) of the National Cooperative Research and Production Act of 1993, 
15 U.S.C. 4301 et seq. (``the Act''), Medical Technology Enterprise 
Consortium (``MTEC'') has filed written notifications simultaneously 
with the Attorney General and the Federal Trade Commission disclosing 
changes in its membership. The notifications were filed for the purpose 
of extending the Act's provisions limiting the recovery of antitrust 
plaintiffs to actual damages under specified circumstances. 
Specifically, Securisyn Medical, LLC, Highlands Ranch, CO; Polaris 
Alpha Advanced Systems, Inc., Aberdeen Proving Ground, MD; Arrevus, 
Inc., Raleigh, NC; Initiate Government Solutions, LLC, North Palm 
Beach, FL; 7-SIGMA Incorporated, Minneapolis, MN; MAE Group, Deerfield, 
NH; Radical Concepts LLC, Brooklyn, NY; Next Generation Stretcher Ltd, 
Raman gan, Israel; Pop Test Oncology LLC aka Palisades Therapeutics, 
Cliffside Park, NJ; George Mason University, Manassas, VA; Phagelux 
(Canada) Inc., Montr[eacute]al, CANADA; MY01 Inc., Montreal, CANADA; 
MilanaPharm, LLC, Tallassee, AL; Leidos, Inc., Reston, VA; InfraScan, 
Inc., Philadelphia, PA; NuShores Biosciences LLC, Little Rock, AR; 
Seran Bioscience, Bend, OR; Celularity, Warren, NJ; Droper Med America, 
LLC, Elgin, SC; tesa Labtec GmbH, Langenfeld, GERMANY; Bio Med 
Sciences, Inc., Allentown, PA; Uluru Inc., Addison, TX; Trailhead 
Biosystems Inc., Cleveland, OH; 410 Medical, Inc., Durham, NC; 
Knowledge Driven LLC, Alexandria, VA; Arsenal Medical, Inc., Watertown, 
MA; University of North Carolina, Institute for Trauma Recovery, Chapel 
Hill, NC; Prep Tech, LLC, Westlake, LA; 21 MedTech, LLC, Burlington, 
NC; Integrum Scientific, LLC, Greensboro, NC; HYPR Life Sciences, Inc., 
Pilot Mountain, NC; X-Therma Inc., Richmond, CA; VoluMetrix LLC, 
Nashville, TN; Howmedica Osteonics Corp. dba Stryker Orthopaedics, 
Mahwah, NJ; NeuEsse Inc., Dunbar, PA; The Geneva Foundation, Tacoma, 
WA; Scinus Cell Expansion B.V., Bilthoven, THE NETHERLANDS; Akron 
Biotechnology, LLC, Boca Raton, FL; RoosterBio Inc., Frederick, MD; 
Aptitude Medical Systems, Santa Barbara, CA; Rho Federal Systems 
Division, Inc. (RhoFED), Chapel Hill, NC; HeadsafelP Pty Ltd Bronte, 
AUSTRALIA; Truecath Inc., Camarillo, CA; Solutions Through Innovative 
Technologies, Inc., Fairborn, OH; Sempulse, LLC, San Marcos, TX; The 
Curators of the University of Missouri on behalf of the University of 
Missouri-Kansas City, Kansas City, MO; Cognitive Medical Systems, Inc., 
San Diego, CA; Hemoclear B.V., Zwolle, NETHERLANDS; Immunexpress Inc., 
Seattle, WA; Klox Technologies, Inc., Laval, CANADA; Opticyte, Inc., 
Seattle, WA; Physcient, Inc., Durham, NC; ActiBioMotion, LLC, 
Coralville, IA; Detact Diagnostics BV, Gronigen, THE NETHERLANDS; 
SurgiBox Inc., Brookline, MA; Cincinnati Automation & Mechatronics, 
LLC, Beavercreek, OH; and Molecular Biologicals, Pasadena, TX; have 
been added as parties to this venture.
    Also, Tallinn University of Technology, Tallin, Estonia; National 
Trauma Institute dba Coalition for National Trauma Research, Marietta, 
TX; East Carolina University, Greenville, NC; EyeSonix LLC, Long Beach, 
CA; ElMindA Ltd., Herzliya, ISRAEL; Propagenix Inc., Rockville, MD; 
Studio Kinection, Inc. dba Kinection, Napa, CA; The Ohio State 
University, Columbus, OH; Elemance, LLC, Clemmons, NC; J. Craig Venter 
Institute (JCVI), Rockville, MD; LambdaVision Incorporated, Farmington, 
CT; Michigan State University, East Lansing, MI; Corvid Technologies, 
Mooresville, NC; Spire, San Francisco, CA; United Solutions, LLC, 
Rockville, MD; Aleo BME, Inc., State College, PA; Cell Guidance Systems 
Ltd, Cambridge, UK; Cole Engineering Services, Inc., Orlando, FL; 
FlexDex, Inc., Brighton, MI; Fortuna Fix, London, UK; Hypatia Project, 
Reston, VA; and MiMedx Group Inc., Marietta, GA; have withdrawn as 
parties to this venture.
    No other changes have been made in either the membership or planned 
activity of the group research project. Membership in this group 
research project remains open, and MTEC intends to file additional 
written notifications disclosing all changes in membership.
    On May 9, 2014 MTEC filed its original notification pursuant to 
Section 6(a) of the Act. The Department of Justice published a notice 
in the Federal Register pursuant to Section 6(b) of the Act on June 9, 
2014 (79 FR 32999).
    The last notification was filed with the Department on January 28, 
2019. A notice was published in the Federal Register pursuant to 
Section 6(b) of the Act on February 28, 2019 (84 FR 6824).

Suzanne Morris,
Chief, Premerger and Division Statistics Unit, Antitrust Division.
[FR Doc. 2019-08997 Filed 5-1-19; 8:45 am]
BILLING CODE 4410-11-P